ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Scope & Guideline
Charting New Frontiers in Gastrointestinal Medicine
Introduction
Aims and Scopes
- Gastrointestinal and Liver Disease Research:
The journal covers a wide array of gastrointestinal and liver diseases, highlighting research on pathophysiology, diagnosis, and treatment options. - Pharmacotherapy and Treatment Strategies:
AP&T emphasizes the role of pharmacotherapy in managing gastrointestinal and liver diseases, including studies on drug efficacy, safety, and guidelines for clinical practice. - Emerging Therapies and Interventions:
The journal frequently publishes research on novel treatment modalities, including biologics, small molecules, and innovative therapies for various digestive disorders. - Clinical Guidelines and Best Practices:
AP&T aims to provide evidence-based recommendations for clinicians, focusing on improving patient outcomes in gastrointestinal and liver diseases. - Patient-Centered Outcomes and Quality of Life:
The journal addresses the importance of patient-reported outcomes, quality of life, and the psychosocial aspects of managing chronic digestive diseases. - Epidemiological Studies and Public Health:
Research related to the epidemiology of gastrointestinal and liver diseases, including risk factors, prevalence, and the impact of public health initiatives, is a key focus area. - Technology and Innovation in Gastroenterology:
AP&T explores advancements in diagnostic and therapeutic technologies, including the use of machine learning and non-invasive testing methods in gastroenterology.
Trending and Emerging
- Metabolic Dysfunction-Associated Liver Disease (MAFLD):
Research on MAFLD is increasingly prominent, focusing on its clinical implications, pathophysiology, and treatment strategies, reflecting a growing recognition of its significance. - Biologics and Targeted Therapies:
The use of biologics and targeted therapies for inflammatory bowel disease (IBD) and other gastrointestinal conditions is a rapidly expanding area of research, with a focus on optimizing treatment regimens. - Artificial Intelligence and Machine Learning:
The application of AI and machine learning in predicting disease outcomes and personalizing treatment approaches is a growing trend, indicating a shift towards data-driven medicine. - Patient-Centered Care and Quality of Life:
There is an increasing emphasis on research that evaluates patient-reported outcomes and quality of life in the context of gastrointestinal diseases, aligning with broader trends in healthcare. - Public Health and Epidemiology:
Studies addressing the epidemiology of liver diseases and gastrointestinal disorders, as well as public health interventions, are gaining traction, reflecting an awareness of the societal impact of these conditions. - Gut Microbiome Research:
The exploration of the gut microbiome’s role in health and disease, particularly in IBD and liver diseases, is an emerging theme, highlighting its significance in therapeutic strategies. - Long-term Outcomes of Chronic Diseases:
Research focusing on the long-term outcomes of chronic gastrointestinal and liver diseases, including the impact of treatment on disease progression and survival, is becoming increasingly important.
Declining or Waning
- Traditional Dietary Interventions:
Research focusing solely on traditional dietary interventions for gastrointestinal diseases has seen reduced emphasis, as newer therapies and pharmacological approaches gain prominence. - Basic Science without Clinical Relevance:
Studies that do not translate into clinical applications or lack direct relevance to patient care are being published less frequently, as the journal prioritizes clinically impactful research. - Single-Center Studies:
There is a noticeable decline in the publication of single-center studies, with a shift towards multi-center and larger cohort studies that yield more generalizable results. - Isolated Pathophysiological Mechanisms:
Research focusing solely on isolated mechanisms of disease without exploring therapeutic implications or clinical outcomes is diminishing, reflecting a preference for integrated approaches. - Non-Pharmacological Treatments:
There appears to be a waning interest in non-pharmacological treatments for digestive diseases, as the journal increasingly emphasizes pharmacotherapy and innovative drug treatments.
Similar Journals
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Elevating standards in gastrointestinal and liver disease research.Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.
Hepatology Forum
Fostering collaboration in the fight against liver disorders.Hepatology Forum is an esteemed journal dedicated to disseminating cutting-edge research and insights in the fields of gastroenterology and hepatology. Published by KARE PUBL in Turkey, this journal serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to advance their knowledge and practices related to liver diseases and gastrointestinal disorders. With an ISSN of 1307-5888 and an E-ISSN of 2757-7392, it features peer-reviewed articles that encompass a wide range of topics from basic research to clinical applications. Although categorized in the Q3 quartile for both gastroenterology and hepatology in 2023, Hepatology Forum continues to show significant potential for growth and impact, as evidenced by its Scopus rankings. Through its commitment to open scientific exchange, the journal not only facilitates the sharing of innovative methodologies and findings but also fosters networking among professionals in the field. As it converges through the years from 2020 to 2024, Hepatology Forum remains an important resource for the advancement of liver health and diseases, appealing to both established experts and emerging scholars alike.
Journal of Gastrointestinal and Liver Diseases
Elevating Research in Gastroenterology and HepatologyThe Journal of Gastrointestinal and Liver Diseases, published by MEDICAL UNIV PRESS in Romania, serves as a pivotal platform for the dissemination of significant research in the fields of gastroenterology and hepatology. Established in 2006, this journal has evolved over the years, currently holding a Q3 rank in Gastroenterology and a Q2 rank in Medicine (miscellaneous), reflecting its commitment to high-quality scholarship and impactful contributions to medical science.
With an ISSN of 1841-8724 and an E-ISSN of 1842-1121, the journal engages a diverse readership of researchers, clinicians, and students passionate about advancing knowledge in gastrointestinal and liver health. While it currently does not operate under an open access model, the journal remains a vital resource for those seeking to stay updated on the latest developments and emerging trends in the field. As it converges towards a broader impact, projected through its coverage until 2024, the Journal of Gastrointestinal and Liver Diseases continues to contribute to the academic landscape, encouraging innovation and comprehensive understanding in digestive health.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
Pioneering insights in pediatric gastroenterology and nutrition.Journal of Pediatric Gastroenterology and Nutrition is a premier academic journal published by Wiley, focusing on the critical intersection of pediatric gastroenterology and nutrition. Established in 1982, this journal has been at the forefront of research and clinical practices for over four decades and continues to contribute invaluable insights to the fields of pediatrics and gastrointestinal health, boasting a Q1 ranking in Pediatrics, Perinatology and Child Health and a Q2 ranking in Gastroenterology as of 2023. The journal features a comprehensive array of original research, review articles, and clinical studies aimed at improving the understanding and management of pediatric gastrointestinal disorders and nutrient imbalances. Edited with expertise, the Journal of Pediatric Gastroenterology and Nutrition serves as an essential resource for clinicians, researchers, and students dedicated to advancing the well-being of children with digestive health issues. Readers can access the journal's impactful research studies through traditional subscriptions.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
Unveiling insights into digestive diseases.REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.
Gastroenterologia y Hepatologia
Unveiling insights that shape the future of digestive health.Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.
Hepatology International
Unveiling insights to transform hepatology practices.Hepatology International is a premier academic journal dedicated to advancing the field of liver research and hepatology. Published by SPRINGER, this journal boasts a prestigious Q1 ranking in Hepatology as of 2023, underscoring its commitment to high-quality research dissemination. The journal’s scope encompasses a wide range of topics related to liver disease, including clinical, translational, and basic science studies. With its impact factor reflecting its relevance and influence in the field, Hepatology International serves as an essential resource for researchers, clinicians, and students aiming to keep abreast of the latest developments and breakthroughs. Though traditionally a subscription-based journal, it offers a vast array of insightful articles that contribute significantly to our understanding of hepatological conditions. The journal continues its trajectory of growth since its inception in 2008, anticipating a convergence of knowledge and innovation through to 2024. Located in the heart of New York City, this journal not only represents a crucial platform for global hepatology research but also fosters a collaborative community of experts dedicated to improving liver health worldwide.
JGH Open
Empowering the Future of Gastrointestinal MedicineJGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.
Clinical Gastroenterology and Hepatology
Exploring Breakthroughs in Liver and Gastrointestinal ResearchClinical Gastroenterology and Hepatology, published by Elsevier Science Inc, stands as a leading journal in the fields of gastroenterology and hepatology. With an ISSN of 1542-3565 and an E-ISSN of 1542-7714, this esteemed publication has earned its place in the top quartile (Q1) of both gastroenterology and hepatology categories as of 2023, ranking 6th out of 167 and 7th out of 82 respectively. The journal aims to disseminate innovative research, clinical studies, and case reports that advance the understanding and treatment of gastrointestinal and liver diseases. Targeted towards researchers, healthcare professionals, and students, it provides crucial insights into emerging therapies and medical advancements. Clinical Gastroenterology and Hepatology is not only a pivotal resource for contemporary gastroenterological research but also fosters collaboration and knowledge-sharing within the medical community. With a converging publication history from 2003 to the present, the journal continues to build on its solid foundation of scientific excellence and relevance.
ZEITSCHRIFT FUR GASTROENTEROLOGIE
Advancing Gastrointestinal Insights Since 1971ZEITSCHRIFT FUR GASTROENTEROLOGIE, published by GEORG THIEME VERLAG KG, stands as a notable journal in the field of gastroenterology since its inception in 1971. With an ISSN of 0044-2771 and an E-ISSN of 1439-7803, this journal focuses on advancing knowledge and research in gastrointestinal health. Operating from Germany, its contributions span various aspects of gastroenterology, providing a platform for both established and emerging scholars to share their findings. As of 2023, ZEITSCHRIFT FUR GASTROENTEROLOGIE is ranked in the Q3 quartile in Gastroenterology and Q4 in Medicine (miscellaneous), reflecting its critical yet developing role in the academic community. Despite its current Scopus rank of #117 out of 167 in the gastroenterology category, the journal aims to foster innovative research and discussions vital for tackling contemporary challenges in gastrointestinal medicine. While it does not offer open access, the journal's extensive archival rigor ensures that pertinent studies remain accessible to professionals and academicians seeking to deepen their understanding and engage with evolving clinical practices.